These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 3525362)

  • 1. Beta cell function in long term NIDDM (type 2) patients and its relation to treatment.
    Snehalatha C; Ramachandran A; Mohan V; Timothy H; Viswanathan M
    Horm Metab Res; 1986 Jun; 18(6):391-4. PubMed ID: 3525362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic beta cell response in insulin treated NIDDM patients limitations of a random C-peptide measurement.
    Snehalatha C; Ramachandran A; Mohan V; Viswanathan M
    Diabete Metab; 1987 Feb; 13(1):27-30. PubMed ID: 3552773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study.
    Levy J; Atkinson AB; Bell PM; McCance DR; Hadden DR
    Diabet Med; 1998 Apr; 15(4):290-6. PubMed ID: 9585393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic reserve and insulin dose in type 2 diabetic patients.
    Calle JR; Rubio MA; Calle-Pascual AL; Bordiu E; Marañés JP
    Diabetes Res; 1993; 23(3):123-9. PubMed ID: 7712686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
    Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
    J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beta cell function in NIDDM patients with secondary failure: a three year follow-up of combined oral hypoglycemic and insulin therapy.
    Greco AV; Caputo S; Bertoli A; Ghirlanda G
    Horm Metab Res; 1992 Jun; 24(6):280-3. PubMed ID: 1634193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The utility of postprandial C-peptide evaluation in type 2 diabetes].
    Prando R; Giusti R; Ciuchi E; Giusto M; Melga PL; Cheli V
    Riv Eur Sci Med Farmacol; 1996; 18(3):95-104. PubMed ID: 9213846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination-therapy with bedtime nph insulin and sulphonylureas gives similar glycaemic control but lower weight gain than insulin twice daily in patients with type 2 diabetes.
    Olsson PO; Lindström T
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):272-7. PubMed ID: 12442064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric emptying in Type II (non-insulin-dependent) diabetes mellitus before and after therapy readjustment: no influence of actual blood glucose concentration.
    Holzäpfel A; Festa A; Stacher-Janotta G; Bergmann H; Shnawa N; Brannath W; Schernthaner G; Stacher G
    Diabetologia; 1999 Dec; 42(12):1410-2. PubMed ID: 10651258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta cell function in insulin-treated non-insulin-dependent diabetic patients.
    Ramachandran A; Snehalatha C; Mohan V; Rao CA; Viswanathan M
    Pancreas; 1986; 1(5):411-4. PubMed ID: 3550785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary failure to oral hypoglycaemic agents in non-obese patients with non-insulin-dependent diabetes is related to reduced insulin release.
    Pontiroli AE; Calderara A; Maffi P; Bonisolli L; Carenini A; Piatti PM; Monti LD; Gallus G; Pozza G; Illeni MT
    Diabete Metab; 1989; 15(2):79-84. PubMed ID: 2661281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin secretion and immuno-genetic markers in diabetics with 'secondary failure' of oral hypoglycemic agents.
    Colman PG; Harrison LC; Tait BD
    Aust N Z J Med; 1985 Apr; 15(2):209-12. PubMed ID: 3896215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-obese adult onset diabetes with oral hypoglycemic agent failure: islet cell autoantibodies or reversible beta cell refractoriness?
    Sá JR; Silva RC; Nasri F; Aguade LC; Velloso L; Chacra AR; Dib SA
    Braz J Med Biol Res; 2003 Oct; 36(10):1301-9. PubMed ID: 14502361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual B cell function in patients with long-standing NIDDM and its relation to metabolic control and diabetic complications.
    Iwase M; Kikuchi M; Nunoi K; Maki Y; Wakisaka M; Wada M; Fujishima M
    Endocrinol Jpn; 1988 Dec; 35(6):803-8. PubMed ID: 3074917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes.
    Groop LC; Pelkonen R; Koskimies S; Bottazzo GF; Doniach D
    Diabetes Care; 1986; 9(2):129-33. PubMed ID: 3516607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of liver echogenicity is correlated to serum c-peptide levels in type 2 diabetic patients.
    Papanas N; Symeonidis G; Mavridis G; Papazoglou D; Giannakis I; Papatheodorou K; Pastore F; Lakasas G; Maltezos E
    Acta Clin Belg; 2006; 61(1):5-9. PubMed ID: 16673610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.